Frontiers | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
The 'anti-hype' vaccine | Nature Biotechnology
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice - ScienceDirect
Michael Hogan - Co-Founder & Chief Scientific Officer @ PathogenDx - Crunchbase Person Profile
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
mRNA vaccine - Wikipedia
Michael Hogan - Senior Advisor - The Regulatory Assistance Project | LinkedIn
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
Short Oligonucleotides Facilitate Co-transcriptional Labeling of RNA at Specific Positions | Journal of the American Chemical Society
Moderna Drops After Losing Appeal Over Drug-Delivery Patents (2)
How mRNA vaccines work without an added adjuvant
Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement | ACS Nano
Michael Hogan, Ph.D. - Vice-President for PepsiCo Foods North America Procurement - PepsiCo | LinkedIn
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses: Molecular Therapy
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
Michael Hogan - Postdoctoral Research Fellow - Children's Hospital of Philadelphia | LinkedIn
Michael Hogan - Postdoctoral Research Fellow - Children's Hospital of Philadelphia | LinkedIn
Machine Learning for Designing Next-Generation mRNA Therapeutics | Accounts of Chemical Research
Vaccines | Free Full-Text | An Update on Self-Amplifying mRNA Vaccine Development
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic - Wang - 2022 - Exploration - Wiley Online Library
